February 2019 Briefing – Urology

Here are what the editors at HealthDay consider to be the most important developments in Urology for February 2019. This roundup includes the latest research news from journal articles, as […]

Here are what the editors at HealthDay consider to be the most important developments in Urology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Adjuvant Tx for Early Testicular Cancer Does Not Harm Sperm

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — For clinical stage I testicular cancer (TC) patients, adjuvant treatment after orchiectomy has no long-term significant effect on sperm production, according to a study published online Feb. 25 in the Annals of Oncology.

Abstract/Full Text

Stewardship Programs Decrease Inpatient Fluoroquinolone Rx

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — Fluoroquinolone stewardship interventions at hospitals are associated with less fluoroquinolone prescribing during hospitalization but not at discharge, according to a study published online Feb. 13 in Clinical Infectious Diseases.

Abstract/Full Text

2014 to 2017 Saw Improvement in Burnout for U.S. Physicians

MONDAY, Feb. 25, 2019 (HealthDay News) — From 2014 to 2017, there was an improvement in burnout and satisfaction with work-life integration among U.S. physicians, according to a study published online Feb. 22 in the Mayo Clinic Proceedings.

Abstract/Full Text

National Health Spending Set to Increase 5.5 Percent Annually

FRIDAY, Feb. 22, 2019 (HealthDay News) — National health spending is projected to increase at an annual rate of 5.5. percent from 2018 to 2027, with fundamental economic and demographic factors the main drivers, according to a report published online Feb. 20 in Health Affairs.

Abstract/Full Text (subscription or payment may be required)

FDA: Gout Drug Uloric Increases Risk of Death

FRIDAY, Feb. 22, 2019 (HealthDay News) — The gout medicine Uloric (febuxostat) carries a higher risk of death than allopurinol, according to the U.S. Food and Drug Administration.

More Information

Most Patients Do Not Disclose Complementary Medicine Use

FRIDAY, Feb. 22, 2019 (HealthDay News) — Just one-third of users of biologically based complementary medicine (CM) disclose their use to traditional health care providers, according to a review published online Feb. 7 in Scientific Reports.

Abstract/Full Text

Intervention Can Reduce Orders for Inpatient Urine Cultures

FRIDAY, Feb. 22, 2019 (HealthDay News) — An intervention that makes changes to urine testing orderables can reduce the urine culturing rate, according to a study published online Feb. 21 in Infection Control & Hospital Epidemiology.

Abstract/Full Text

Many Experience Improvement in Sex Life After Bariatric Surgery

THURSDAY, Feb. 21, 2019 (HealthDay News) — About half of women and men who report some level of dissatisfaction with their sexual life prior to bariatric surgery experience clinically meaningful improvement during five years of follow-up, according to a study published online Feb. 20 in JAMA Surgery.

Abstract/Full Text

1 | 2 | 3
Page 1 of 3
Next »